- Home
- STCN vs MAIA Comparison
STCN vs MAIA Comparison
Compare STCN & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STCN
- MAIA
- Stock Information
- Founded
- STCN 1986
- MAIA 2018
- Country
- STCN United States
- MAIA United States
- Employees
- STCN N/A
- MAIA N/A
- Industry
- STCN Advertising
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- STCN Consumer Discretionary
- MAIA Health Care
- Exchange
- STCN Nasdaq
- MAIA Nasdaq
- Market Cap
- STCN 63.4M
- MAIA 62.4M
- IPO Year
- STCN 1994
- MAIA 2022
- Fundamental
- Price
- STCN $10.40
- MAIA $2.82
- Analyst Decision
- STCN
- MAIA
- Analyst Count
- STCN 0
- MAIA 0
- Target Price
- STCN N/A
- MAIA N/A
- AVG Volume (30 Days)
- STCN 11.9K
- MAIA 60.0K
- Earning Date
- STCN 12-12-2024
- MAIA 11-05-2024
- Dividend Yield
- STCN N/A
- MAIA N/A
- EPS Growth
- STCN 203.29
- MAIA N/A
- EPS
- STCN 3.17
- MAIA N/A
- Revenue
- STCN $169,044,000.00
- MAIA N/A
- Revenue This Year
- STCN N/A
- MAIA N/A
- Revenue Next Year
- STCN N/A
- MAIA N/A
- P/E Ratio
- STCN $3.19
- MAIA N/A
- Revenue Growth
- STCN N/A
- MAIA N/A
- 52 Week Low
- STCN $7.36
- MAIA $0.82
- 52 Week High
- STCN $13.00
- MAIA $5.99
- Technical
- Relative Strength Index (RSI)
- STCN 57.19
- MAIA 50.98
- Support Level
- STCN $9.90
- MAIA $2.36
- Resistance Level
- STCN $10.29
- MAIA $2.72
- Average True Range (ATR)
- STCN 0.39
- MAIA 0.22
- MACD
- STCN 0.11
- MAIA 0.02
- Stochastic Oscillator
- STCN 100.00
- MAIA 72.28
About STCN Steel Connect Inc.
Steel Connect Inc is a diversified holding company. The company's operating segment include Direct Marketing and Supply Chain. It generates maximum revenue from the Direct Marketing segment. Geographically, it derives a majority of revenue from the United States and also has a presence in China; Netherlands, and others. The company serves clients in various industries including consumer electronics, communications, computing, software, storage, and retail industries.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.